Status:

TERMINATED

A Study of High-Risk Oral Cavity Cancer

Lead Sponsor:

National Health Research Institutes, Taiwan

Collaborating Sponsors:

National Taiwan University Hospital

Chang Gung Memorial Hospital

Conditions:

Oral Cavity Cancer

Eligibility:

All Genders

Up to 70 years

Phase:

PHASE2

PHASE3

Brief Summary

Objectives: 1. To study the effect of anti-angiogenesis therapy on reducing the recurrence of high-risk oral cavity cancer patients after curative local treatment. 2. To study the toxicity and compli...

Detailed Description

Type and number of patients: Patients with resectable oral cancer of clinical stage N2, 3 or skin-involved T4 will be enrolled. Sample size at the first stage is 64 patients per group and the total ...

Eligibility Criteria

Inclusion

  • Histologically proved oral cavity squamous cell carcinoma (buccal and mobile tongue).
  • Clinical stage T4a with skin involvement or resectable N2-3 by UICC/AJCC 1997 staging system.(24)
  • Curative-intent operation feasible and arranged.
  • Eastern Cooperative Oncology Group performance status ≦ 1.
  • A leukocyte count ≧3750/μL, Hb ≧10 g/dL, and a platelet count ≧100,000/μL.
  • A serum bilirubin level \< 1.5 UNL (upper normal limit), serum creatinine level \< 1.5 UNL or creatinine clearance \> 60 mL/min.
  • Age less than 70 years old
  • Informed consent signed.

Exclusion

  • Evidence of distant metastatic.
  • Presence of another malignancy other than treated squamous/basal cell carcinoma of the skin.
  • Presence of uncontrolled hypertension, poorly controlled heart failure.
  • Presence of active infection.
  • Patients who have been or are being treated with chemotherapy, radiotherapy, immunotherapy, or other experimental therapies.
  • Women who test positive for pregnancy. Note: Patients received neck lymph node biopsy will be eligible and the stage will be given according to the preoperative status.

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00934739

Start Date

June 1 2007

End Date

December 1 2012

Last Update

February 25 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.